Your session is about to expire
← Back to Search
Self-Collected Screening Workshops for Cervical Cancer
Study Summary
This trial will compare whether educational workshops on HPV and self-collected screenings will increase participation in cervical cancer screenings among Hmong and Karenni refugee and immigrant populations in Wisconsin compared to just offering clinician collected screenings.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You can speak and understand Karenni language fluently.You are unable to make sound decisions for yourself.You are pregnant.You can speak and understand Hmong language fluently.
- Group 1: Control
- Group 2: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are they still accepting new participants into this research study?
"Clinicaltrials.gov states that this trial, which was first posted on August 13th 2022 and last modified on the 31st of same month, is no longer seeking patients. However, there are 318 other clinical trials in search for individuals at present time."
What qualifications make one an optimal candidate for this medical experiment?
"This medical trial seeks 250 participants who possess the eef1a1 protein, human and are between 25 to 65 years of age. Additionally, all potential patients must have a working understanding of English, Hmong or Karenni."
Does this research experiment accommodate those under the age of 30?
"This clinical trial is exclusively open to adults aged 25-65. Meanwhile, there are 10 trials for younger individuals and 284 studies that focus on those over 65 years old."
Share this study with friends
Copy Link
Messenger